Printer Friendly

DIMENSIONAL MEDICINE REPORTS SECOND QUARTER RESULTS

 MINNEAPOLIS, Nov. 18 ~PRNewswire~ -- Dimensional Medicine, Inc. (NASDAQ: DMED) (DMI), a Minneapolis-based developer and marketer of radiology-related systems, reports operating revenues for the second quarter ended Sept. 30, 1992 of $933,262 compared with $1,508,607 for the second quarter last year. The net loss of $332,502, or $.09 per share, for the quarter compares with net income of $11,097, or $.003 per share in the prior year.
 For the six months ended Sept. 30, 1992, DMI reported operating revenue of $2,046,767 and a net loss of $440,833, or $.12 per share. This compares with operating revenues of $2,858,715 and a net loss of $150,698, or $.04 per share for the six months ended Sept. 30, 1991.
 DMI also announced that Marlin G. Rudebusch has been elected to the board of directors of the company. Rudebusch is director, business development and marketing for Medtronic, Inc., Neuro Division.
 David H. Littlefield, president and CEO, commented, "We are very pleased to have Marlin as a DMI director. Mr. Rudebusch's marketing background and healthcare marketplace experience adds an important skill set to our team. The quarter and year-to-date financials are not consistent with expectations; however, a business that relies on the execution of about a dozen new contracts per year is not able to deliver predictable quarterly results. Four contracts totaling approximately $1.2 million are pending final action, where Phase I training has been completed in each case. Revenue recognition will be accelerated due to already completed tasks. We have also completed marketing agreements with a national buying group and with a major HIS vendor. We fully expect operating results to improve in the second half."
 DIMENSIONAL MEDICINE, INC.
 RESULTS OF OPERATIONS
 (Unaudited)
 Three Months Ended Six Months Ended
 9~30~92 9~30~91 9~30~92 9~30~91
 Operating revenues $933,263 $1,508,607 $2,046,767 $2,858,715
 Operating costs &
 expenses 1,246,823 1,498,869 2,486,889 2,997,829
 Operating income
 (loss) (313,560) 9,738 (440,122) (139,114)
 Other (income) expense 18,942 (1,359) 11,584 711
 Net income (loss) $(332,502) $11,097 $(440,833) $(150,698)
 Net income (loss)
 per share $(.09) $.003 $(.12) $(.04)
 Weighted average number of
 shares outstanding 3,673,346 3,673,346 3,673,346 3,673,346
 Dimensional Medicine, Inc. designs, develops and markets computerized peripheral equipment and systems to the radiology medical market. The company is headquartered in Minnetonka, Minn.
 -0- 11~18~92
 ~CONTACT: Richard G. May of Dimensional Medicine, 612-938-8280~
 (DMED)


CO: Dimensional Medicine, Inc. ST: Minnesota IN: MTC SU: ERN

KH -- MN005 -- 2292 11~18~92 11:12 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 18, 1992
Words:451
Previous Article:NASH FINCH BOARD DECLARES REGULAR QUARTERLY, EXTRA DIVIDENDS
Next Article:BOSTON TECHNOLOGY ANNOUNCES THIRD QUARTER RESULTS: COMPANY POSTS PROFIT OF 5 CENTS PER SHARE
Topics:


Related Articles
DIMENSIONAL MEDICINE REPORTS THIRD QUARTER RESULTS
DIMENSIONAL MEDICINE REPORTS SECOND QUARTER RESULTS
DIMENSIONAL MEDICINE REPORTS THIRD QUARTER RESULTS
BIO-VASCULAR REPORTS PROFIT IN SECOND QUARTER
MICRO BIO-MEDICS, INC. REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER AND SIX MONTHS ENDED MAY 31, 1995
DIMENSIONAL MEDICINE REPORTS FIRST QUARTER RESULTS
DIMENSIONAL MEDICINE REPORTS SECOND QUARTER AND YEAR-TO-DATE RESULTS
DIMENSIONAL MEDICINE REPORTS EXPECTED FOURTH QUARTER AND YEAR-END RESULTS
FDA Clears Clarity(TM) Software Release by Endocardial Solutions.
Bionx Implants Announces Second Quarter 2000 Results.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters